Inbunden, Engelska, 2017
Del 13 i serien Resistance to Targeted Anti-Cancer Therapeutics
Resistance to Molecular Therapies for Hepatocellular Carcinoma
2199 kr
Beställningsvara. Skickas inom 10-15 vardagar. Fri frakt för medlemmar vid köp för minst 249 kr.
Finns i fler format
Beskrivning
This volume evaluates the clinical patterns of resistance to sorafenib, the impact of trial design in the second-line setting and the current gold standard to define radiological resistance; describes the molecular mechanisms responsible for treatment resistance in HCC patients, including components of the immune system and tumor microenvironment; determines the role of the cancer stem cell phenotype in resistance; reviews the experimental models to study resistance; and addresses new approaches to overcome resistance to sorafenib, using successful examples from other malignancies.
Produktinformation
- Utgivningsdatum: 2017-07-27
- Mått: 155 x 235 x 15 mm
- Vikt: 366 g
- Format: Inbunden
- Språk: Engelska
- Serie: Resistance to Targeted Anti-Cancer Therapeutics
- Antal sidor: 147
- Förlag: Springer International Publishing AG
- ISBN: 9783319561967
Utforska kategorier
Mer information
Augusto Villanueva, MD, PhD, is Assistant Professor, Division of Liver Diseases, Liver Cancer Program, Department of Medicine, Tisch Cancer Institute, Icahn School of Medicine, NYC.
Butikslager
Ej i lager i butik.
Betyg & recensioner
0 recensioner
Inga recensioner tillgängliga.